Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics
Cancer continues to be one of the leading causes of death worldwide, and conventional cancer therapies such as chemotherapy, radiation therapy, and surgery have limitations. RNA therapy and cancer vaccines hold considerable promise as an alternative to conventional therapies for their ability to ena...
Saved in:
Main Authors: | Olga V. Sergeeva, Liang Luo, Anthony Guiseppi-Elie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2024.1499474/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DNA vaccines as promising immuno-therapeutics against cancer: a new insight
by: Alireza Shariati, et al.
Published: (2025-01-01) -
Potential and development of cellular vesicle vaccines in cancer immunotherapy
by: Wenxi Zhao, et al.
Published: (2025-01-01) -
A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01) -
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
by: Weisen Ning, et al.
Published: (2025-01-01) -
Retinal Artery Occlusion: A Review of Current Management Practices
by: Hannah Yu, et al.
Published: (2024-12-01)